You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

high grade astrocytoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,

Not yet recruiting
  • Anaplastic Astrocytoma
  • +17 more
    • (no location specified)
    Jun 28, 2023

    Glioblastoma, Anaplastic Astrocytoma, Astrocytoma Trial in New York (Adaptive Radiotherapy)

    Recruiting
    • Glioblastoma
    • +3 more
    • Adaptive Radiotherapy
    • New York, New York
      Columbia University Irving Medical Center
    Oct 27, 2023

    Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial in United States (INCB7839)

    Recruiting
    • Glioblastoma Multiforme
    • +5 more
    • Los Angeles, California
    • +12 more
    Jan 9, 2023

    Supramaximal Resection Versus Maximal Resection for High-Grade

    Recruiting
    • Glioblastoma
    • +11 more
    • Supramaximal resection
    • Maximal safe resection
    • San Francisco, California
    • +7 more
    Nov 1, 2023

    Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

    Recruiting
    • Malignant Glioma of Brain
    • +8 more
    • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
    • Detroit, Michigan
      Henry Ford Health System
    Jan 9, 2023

    Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients

    Recruiting
    • Medulloblastoma
    • +7 more
    • SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
    • +2 more
    • Buffalo, New York
    • +2 more
    Jul 8, 2022

    Glioblastoma, Astrocytoma, Oligodendroglioma Trial (OKN-007)

    Withdrawn
    • Glioblastoma
    • +2 more
    • (no location specified)
    Oct 5, 2022

    High-grade Glioma, Oligodendroglioma, Astrocytoma Trial (Low-dose OKN-007, BID, Low-dose OKN-007, TID, Mid-dose OKN-007, TID)

    Not yet recruiting
    • High-grade Glioma
    • +3 more
    • Low-dose OKN-007, BID
    • +3 more
    • (no location specified)
    Sep 26, 2022

    Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

    Active, not recruiting
    • Glioma, Malignant
    • +4 more
    • Tampa, Florida
      Moffitt Cancer Center
    Nov 28, 2022

    Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

    Not yet recruiting
    • Recurrent High Grade Glioma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Vascular Habitats Within Astrocytoma Grade 4 at Molecular,

    Recruiting
    • Astrocytoma, Grade IV
    • +7 more
      • Valencia, Spain
        Biomedical Data Science Lab. Universitat Politècnica de València
      May 11, 2022

      Recurrent High-grade Glioma, Recurrent Glioblastoma, Recurrent Anaplastic Astrocytoma Trial in Incheon (500mg/kg/3hr followed by

      Recruiting
      • Recurrent High-grade Glioma
      • +3 more
      • 500mg/kg/3hr followed by neutron irradiation to reach maximum brain dose of 9Gy-Eq
      • +2 more
      • Incheon, Korea, Republic of
        Gachon University Gil Medical Center
      Feb 19, 2023

      Glioblastomas, Sarcoma, Astrocytoma Trial run by the NCI (Enhanced Mindfulness Intervention, Psychoeducation)

      Completed
      • Glioblastomas
      • +4 more
      • Enhanced Mindfulness Intervention
      • Psychoeducation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Sep 14, 2022

      Tumors, High Grade Glioma, Glioblastoma Multiforme Trial in Birmingham (Biological G207)

      Not yet recruiting
      • Neoplasms
      • +7 more
      • Biological G207
      • Birmingham, Alabama
        Children's of Alabama
      Jun 1, 2022

      Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

      Withdrawn
      • Recurrent Anaplastic Astrocytoma
      • +7 more
      • Neural Stem Cells-expressing CRAd-S-pk7
      • Resection
      • (no location specified)
      Nov 22, 2022

      Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma Trial in United States (ribociclib, Everolimus)

      Completed
      • Diffuse Intrinsic Pontine Glioma
      • +6 more
      • Washington, District of Columbia
      • +6 more
      Jan 12, 2023

      Targeted Pediatric High-Grade Glioma Therapy

      Not yet recruiting
      • High Grade Glioma
      • +8 more
        • Aurora, Colorado
        • +17 more
        May 1, 2023

        Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)

        Completed
        • Diffuse Intrinsic Pontine Glioma
        • +2 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 30, 2021

        Recurrent Anaplastic Astrocytoma, Recurrent Anaplastic Oligoastrocytoma, Recurrent Anaplastic Oligodendroglioma Trial in Duarte

        Active, not recruiting
        • Recurrent Anaplastic Astrocytoma
        • +6 more
        • Carboxylesterase-expressing Allogeneic Neural Stem Cells
        • +4 more
        • Duarte, California
          City of Hope Medical Center
        Jun 7, 2022

        Prospective Validation of Imaging Biomarkers Calculated at

        Recruiting
        • Astrocytoma, Grade IV
          • Valencia, Spain
            Universitat Politècnica de València
          Feb 7, 2022

          Malignant Glioma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Miami (biological, drug, procedure)

          Completed
          • Malignant Glioma
          • +3 more
          • Dendritic Cell Vaccine
          • +3 more
          • Miami, Florida
            University of Miami
          Jul 19, 2022

          Glioblastoma Multiforme, Anaplastic Astrocytoma, Malignant Brain Tumor Trial in Indianapolis (Cabozantinib)

          Terminated
          Has Results
          • Glioblastoma Multiforme
          • +3 more
          • Indianapolis, Indiana
            Riley Hospital for Children at IU Health
          Jul 21, 2022

          Astrocytoma, Grade II, Astrocytoma, Grade III Trial in United States (TTFields with adjuvant temozolomide)

          Terminated
          Has Results
          • Astrocytoma, Grade II
          • Astrocytoma, Grade III
          • TTFields with adjuvant temozolomide
          • Gainesville, Florida
          • +4 more
          Aug 26, 2021

          Astrocytoma, Brain Cancer, Brain Metastases Trial in Kogarah, Liverpool (QBS10072S)

          Recruiting
          • Astrocytoma
          • +22 more
          • Kogarah, New South Wales, Australia
          • +1 more
          Apr 18, 2022

          Gliosarcoma, Recurrent Glioblastoma, Astrocytoma of Brain Trial in Palo Alto (Laboratory Biomarker Analysis, Pharmacological

          Completed
          • Gliosarcoma
          • +3 more
          • Laboratory Biomarker Analysis
          • +2 more
          • Palo Alto, California
            Stanford University, School of Medicine
          Aug 9, 2021